111 related articles for article (PubMed ID: 8484978)
1. Psychological reactions in public melanoma screening.
Brandberg Y; Bolund C; Michelson H; Månsson-Brahme E; Ringborg U; Sjödén PO
Eur J Cancer; 1993; 29A(6):860-3. PubMed ID: 8484978
[TBL] [Abstract][Full Text] [Related]
2. Psychological reactions in patients with malignant melanoma.
Brandberg Y; Månsson-Brahme E; Ringborg U; Sjödén PO
Eur J Cancer; 1995; 31A(2):157-62. PubMed ID: 7718319
[TBL] [Abstract][Full Text] [Related]
3. [No symptoms of unnecessary anxiety or false confidence among participants of screening for malignant melanoma].
Brandberg Y; Sjödén O; Michelson H
Lakartidningen; 1992 Sep; 89(36):2827. PubMed ID: 1405875
[No Abstract] [Full Text] [Related]
4. Factors related to non-attendance in a population based melanoma screening program.
Bergenmar M; Törnberg S; Brandberg Y
Psychooncology; 1997 Sep; 6(3):218-26. PubMed ID: 9313288
[TBL] [Abstract][Full Text] [Related]
5. Depression, anxiety and quality of life in long-term survivors of malignant melanoma: a register-based cohort study.
Beutel ME; Fischbeck S; Binder H; Blettner M; Brähler E; Emrich K; Friedrich-Mai P; Imruck BH; Weyer V; Zeissig SR
PLoS One; 2015; 10(1):e0116440. PubMed ID: 25615573
[TBL] [Abstract][Full Text] [Related]
6. Psychological characteristics of early-stage melanoma patients: a cross-sectional study on 204 patients.
Tesio V; Ribero S; Castelli L; Bassino S; Leombruni P; Caliendo V; Grassi M; Lauro D; Macripò G; Torta RGV
Melanoma Res; 2017 Jun; 27(3):277-280. PubMed ID: 28207426
[TBL] [Abstract][Full Text] [Related]
7. Psychosocial impact of skin biopsies in the setting of melanoma screening: a cross-sectional survey.
Matthews NH; Risica PM; Ferris LK; Beatson M; Saul M; Geller AC; Solano F; Kirkwood JM; Weinstock MA
Br J Dermatol; 2019 Mar; 180(3):664-665. PubMed ID: 30183068
[No Abstract] [Full Text] [Related]
8. [Behavior and attitude regarding skin cancer prevention and early detection in relation to current knowledge--studies of visitors to an industrial fair].
Paul E; Agathos M; Balda BR; Bauerdorf R; Beilner-Track R; Detmar U; Elsner P; Frühauf W; Galli KH; von Hintzenstern J
Gesundheitswesen; 1992 Jul; 54(7):325-30. PubMed ID: 1504483
[TBL] [Abstract][Full Text] [Related]
9. The psychological effects of breast screening in terms of patients' perceived health anxieties.
Swanson V; McIntosh IB; Power KG; Dobson H
Br J Clin Pract; 1996; 50(3):129-35. PubMed ID: 8733330
[TBL] [Abstract][Full Text] [Related]
10. Cognitive-behavioral intervention for distress in patients with melanoma: comparison with standard medical care and impact on quality of life.
Trask PC; Paterson AG; Griffith KA; Riba MB; Schwartz JL
Cancer; 2003 Aug; 98(4):854-64. PubMed ID: 12910531
[TBL] [Abstract][Full Text] [Related]
11. Psychological status and illness perceptions in patients with melanoma.
Vurnek Zivković M; Buljan M; Blajić I; Situm M
Coll Antropol; 2008 Oct; 32 Suppl 2():75-8. PubMed ID: 19140271
[TBL] [Abstract][Full Text] [Related]
12. The different psychological profiles of subjects attending melanoma screening campaigns and those delaying diagnosis: an aid for designing preventive campaigns?
Forghieri M; Longo C; Galeazzi GM; Rigatelli M; Seidenari S; Pellacani G
Eur J Dermatol; 2010; 20(6):802-7. PubMed ID: 20956101
[TBL] [Abstract][Full Text] [Related]
13. Supportive care needs, anxiety, depression and quality of life amongst newly diagnosed patients with localised invasive cutaneous melanoma in Queensland, Australia.
Beesley VL; Smithers BM; Khosrotehrani K; Khatun M; O'Rourke P; Hughes MC; Malt MK; Zonta MJ; Bayley GJ; Barbour AP; Brown LJ; D'Arcy J; Allan CP; Green AC
Psychooncology; 2015 Jul; 24(7):763-70. PubMed ID: 25355178
[TBL] [Abstract][Full Text] [Related]
14. Psychological status and coping with illness in patients with malignant melanoma.
Vurnek M; Buljan M; Situm M
Coll Antropol; 2007 Jan; 31 Suppl 1():53-6. PubMed ID: 17469751
[TBL] [Abstract][Full Text] [Related]
15. Psychological responses and coping strategies among patients with malignant melanoma: a systematic review of the literature.
Kasparian NA; McLoone JK; Butow PN
Arch Dermatol; 2009 Dec; 145(12):1415-27. PubMed ID: 20026852
[TBL] [Abstract][Full Text] [Related]
16. A quality-of-life study in high-risk (thickness > = or 2 mm) cutaneous melanoma patients in a randomized trial of 1-cm versus 3-cm surgical excision margins.
Newton-Bishop JA; Nolan C; Turner F; McCabe M; Boxer C; Thomas JM; Coombes G; A'Hern RP; Barrett JH
J Investig Dermatol Symp Proc; 2004 Mar; 9(2):152-9. PubMed ID: 15083783
[TBL] [Abstract][Full Text] [Related]
17. A community study of delay in presenting with signs of melanoma to medical practitioners.
Hennrikus D; Girgis A; Redman S; Sanson-Fisher RW
Arch Dermatol; 1991 Mar; 127(3):356-61. PubMed ID: 1998366
[TBL] [Abstract][Full Text] [Related]
18. Anxiety and depressive symptoms measured by the Hospital Anxiety and Depression Scale as predictors of time to recurrence in localized cutaneous melanoma.
Bergenmar M; Nilsson B; Hansson J; Brandberg Y
Acta Oncol; 2004; 43(2):161-8. PubMed ID: 15163164
[TBL] [Abstract][Full Text] [Related]
19. Psychological impact of screening for familial ovarian cancer: reactions to initial assessment.
Erlick Robinson G; Rosen BP; Bradley LN; Rockert WG; Carr ML; Cole DE; Murphy KJ
Gynecol Oncol; 1997 May; 65(2):197-205. PubMed ID: 9159325
[TBL] [Abstract][Full Text] [Related]
20. [The epidemiological approach and the good of the single individual].
Caputo R
Epidemiol Prev; 2000; 24(6):242-3. PubMed ID: 11219195
[No Abstract] [Full Text] [Related]
[Next] [New Search]
